Yahoo Finance

Press Release: Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78% and caps out-of-pocket Lantus costs at $35 for all patients with commercial insurance

Paris, March 16, 2023. Sanofi announces that it will cut the list price of Lantus (insulin glargine injection) 100 Units/mL, its most widely prescribed insulin in the U.S., by 78 percent. The company ...
FiercePharma

Lantus® Initiation after Metformin Achieved Superior Glycemic Control versus Sitagliptin in Type 2 Diabetes

PARIS, France, June 9, 2012-- Sanofi (EURONEXT : SAN and NYSE : SNY) announced today that people with early type 2 diabetes uncontrolled on metformin demonstrated superior HbA1c - glycated hemoglobin ...
Medindia

Lantus (Insulin) Drug Price and Information

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Insulin (Lantus) is a hormone produced in the ...
Zawya

Sanofi-aventis announces results of research in the use of Lantus ( insulin glargine [rDNA] injection )

Today, Sanofi-aventis announced the results of new analysis that found a significantly lower risk of nocturnal hypoglycemia with Lantus (insulin glargine [rDNA] injection) as compared to NPH insulin.
Monthly Prescribing Reference

Continuous Insulin Glargine vs. Detemir Impact on A1C Levels

Sanofi announced the results of a real world outcome study on insulin glargine (Lantus) injection vs. insulin detemir (Levemir; Novo Nordisk) injection on A1C levels. The research was presented at the ...